p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia

Rüdiger Klaes, Axel Benner, Tibor Friedrich, Rüdiger Ridder, Simon Herrington, David Jenkins, Robert J Kurman, Dietmar Schmidt, Mark Stoler, Magnus Von Knebel Doeberitz

Research output: Contribution to journalArticle

Abstract

It has been repeatedly shown that there is a substantial lack of interobserver reproducibility in the histologic diagnosis of cervical intraepithelial neoplasia (CIN), which might be improved by a more specific diagnostic biomarker. Cervical cancer and CIN, but not other cervical epithelia, express high levels of the cyclin-dependent kinase inhibitor p16INK4a, suggesting that staining for this marker could help to more precisely identify CIN in tissue sections and therefore reduce variation in interpretation of cervical lesions. To test this hypothesis, 194 cervical cone biopsy samples were selected from a routine histopathology laboratory. Two consecutive sections from each biopsy were stained with hematoxylin and eosin and with a p16INK4a-specific monoclonal antibody, respectively. Five experienced cervical pathologists examined the slides. The agreement in the diagnosis between pairs or groups of observers was calculated by kappa statistics. Significant discrepancies were observed in the diagnostic interpretation of hematoxylin and eosin-stained slides, particularly for low-grade lesions (kappa value 0.60 [95% confidence interval 0.58-0.63]). There was significantly better agreement in the interpretation of p16INK4a expression (kappa value 0.91 [95% confidence interval 0.84-0.99]). Expression of p16INK4a was restricted to CIN 2/CIN 3, CIN 1 associated with high-risk human papillomavirus, or cervical cancer. p16INK4a immunostaining allowed precise identification of even small CIN or cervical cancer lesions in biopsy sections and helped to reduce interobserver variation in the histopathologic interpretation of cervical biopsy specimens. Thus, p16INK4a immunohistochemistry can reduce false-negative and false-positive biopsy interpretation and thereby significantly improve cervical (pre)-cancer diagnosis.

Original languageEnglish (US)
Pages (from-to)1389-1399
Number of pages11
JournalAmerican Journal of Surgical Pathology
Volume26
Issue number11
DOIs
StatePublished - Nov 1 2002
Externally publishedYes

Fingerprint

Cervical Intraepithelial Neoplasia
Immunohistochemistry
Uterine Cervical Neoplasms
Biopsy
Hematoxylin
Eosine Yellowish-(YS)
Confidence Intervals
Observer Variation
Cyclin-Dependent Kinases
Epithelium
Biomarkers
Monoclonal Antibodies
Staining and Labeling

Keywords

  • Biomarker
  • Cervical intraepithelial neoplasia
  • CIN
  • Histologic diagnosis
  • Immunohistochemistry
  • Interobserver variability
  • p16
  • Tumor marker

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine

Cite this

Klaes, R., Benner, A., Friedrich, T., Ridder, R., Herrington, S., Jenkins, D., ... Von Knebel Doeberitz, M. (2002). p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. American Journal of Surgical Pathology, 26(11), 1389-1399. https://doi.org/10.1097/00000478-200211000-00001

p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. / Klaes, Rüdiger; Benner, Axel; Friedrich, Tibor; Ridder, Rüdiger; Herrington, Simon; Jenkins, David; Kurman, Robert J; Schmidt, Dietmar; Stoler, Mark; Von Knebel Doeberitz, Magnus.

In: American Journal of Surgical Pathology, Vol. 26, No. 11, 01.11.2002, p. 1389-1399.

Research output: Contribution to journalArticle

Klaes, R, Benner, A, Friedrich, T, Ridder, R, Herrington, S, Jenkins, D, Kurman, RJ, Schmidt, D, Stoler, M & Von Knebel Doeberitz, M 2002, 'p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia', American Journal of Surgical Pathology, vol. 26, no. 11, pp. 1389-1399. https://doi.org/10.1097/00000478-200211000-00001
Klaes, Rüdiger ; Benner, Axel ; Friedrich, Tibor ; Ridder, Rüdiger ; Herrington, Simon ; Jenkins, David ; Kurman, Robert J ; Schmidt, Dietmar ; Stoler, Mark ; Von Knebel Doeberitz, Magnus. / p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. In: American Journal of Surgical Pathology. 2002 ; Vol. 26, No. 11. pp. 1389-1399.
@article{da89ecaadd8448ac8344c52d51feac2a,
title = "p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia",
abstract = "It has been repeatedly shown that there is a substantial lack of interobserver reproducibility in the histologic diagnosis of cervical intraepithelial neoplasia (CIN), which might be improved by a more specific diagnostic biomarker. Cervical cancer and CIN, but not other cervical epithelia, express high levels of the cyclin-dependent kinase inhibitor p16INK4a, suggesting that staining for this marker could help to more precisely identify CIN in tissue sections and therefore reduce variation in interpretation of cervical lesions. To test this hypothesis, 194 cervical cone biopsy samples were selected from a routine histopathology laboratory. Two consecutive sections from each biopsy were stained with hematoxylin and eosin and with a p16INK4a-specific monoclonal antibody, respectively. Five experienced cervical pathologists examined the slides. The agreement in the diagnosis between pairs or groups of observers was calculated by kappa statistics. Significant discrepancies were observed in the diagnostic interpretation of hematoxylin and eosin-stained slides, particularly for low-grade lesions (kappa value 0.60 [95{\%} confidence interval 0.58-0.63]). There was significantly better agreement in the interpretation of p16INK4a expression (kappa value 0.91 [95{\%} confidence interval 0.84-0.99]). Expression of p16INK4a was restricted to CIN 2/CIN 3, CIN 1 associated with high-risk human papillomavirus, or cervical cancer. p16INK4a immunostaining allowed precise identification of even small CIN or cervical cancer lesions in biopsy sections and helped to reduce interobserver variation in the histopathologic interpretation of cervical biopsy specimens. Thus, p16INK4a immunohistochemistry can reduce false-negative and false-positive biopsy interpretation and thereby significantly improve cervical (pre)-cancer diagnosis.",
keywords = "Biomarker, Cervical intraepithelial neoplasia, CIN, Histologic diagnosis, Immunohistochemistry, Interobserver variability, p16, Tumor marker",
author = "R{\"u}diger Klaes and Axel Benner and Tibor Friedrich and R{\"u}diger Ridder and Simon Herrington and David Jenkins and Kurman, {Robert J} and Dietmar Schmidt and Mark Stoler and {Von Knebel Doeberitz}, Magnus",
year = "2002",
month = "11",
day = "1",
doi = "10.1097/00000478-200211000-00001",
language = "English (US)",
volume = "26",
pages = "1389--1399",
journal = "American Journal of Surgical Pathology",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia

AU - Klaes, Rüdiger

AU - Benner, Axel

AU - Friedrich, Tibor

AU - Ridder, Rüdiger

AU - Herrington, Simon

AU - Jenkins, David

AU - Kurman, Robert J

AU - Schmidt, Dietmar

AU - Stoler, Mark

AU - Von Knebel Doeberitz, Magnus

PY - 2002/11/1

Y1 - 2002/11/1

N2 - It has been repeatedly shown that there is a substantial lack of interobserver reproducibility in the histologic diagnosis of cervical intraepithelial neoplasia (CIN), which might be improved by a more specific diagnostic biomarker. Cervical cancer and CIN, but not other cervical epithelia, express high levels of the cyclin-dependent kinase inhibitor p16INK4a, suggesting that staining for this marker could help to more precisely identify CIN in tissue sections and therefore reduce variation in interpretation of cervical lesions. To test this hypothesis, 194 cervical cone biopsy samples were selected from a routine histopathology laboratory. Two consecutive sections from each biopsy were stained with hematoxylin and eosin and with a p16INK4a-specific monoclonal antibody, respectively. Five experienced cervical pathologists examined the slides. The agreement in the diagnosis between pairs or groups of observers was calculated by kappa statistics. Significant discrepancies were observed in the diagnostic interpretation of hematoxylin and eosin-stained slides, particularly for low-grade lesions (kappa value 0.60 [95% confidence interval 0.58-0.63]). There was significantly better agreement in the interpretation of p16INK4a expression (kappa value 0.91 [95% confidence interval 0.84-0.99]). Expression of p16INK4a was restricted to CIN 2/CIN 3, CIN 1 associated with high-risk human papillomavirus, or cervical cancer. p16INK4a immunostaining allowed precise identification of even small CIN or cervical cancer lesions in biopsy sections and helped to reduce interobserver variation in the histopathologic interpretation of cervical biopsy specimens. Thus, p16INK4a immunohistochemistry can reduce false-negative and false-positive biopsy interpretation and thereby significantly improve cervical (pre)-cancer diagnosis.

AB - It has been repeatedly shown that there is a substantial lack of interobserver reproducibility in the histologic diagnosis of cervical intraepithelial neoplasia (CIN), which might be improved by a more specific diagnostic biomarker. Cervical cancer and CIN, but not other cervical epithelia, express high levels of the cyclin-dependent kinase inhibitor p16INK4a, suggesting that staining for this marker could help to more precisely identify CIN in tissue sections and therefore reduce variation in interpretation of cervical lesions. To test this hypothesis, 194 cervical cone biopsy samples were selected from a routine histopathology laboratory. Two consecutive sections from each biopsy were stained with hematoxylin and eosin and with a p16INK4a-specific monoclonal antibody, respectively. Five experienced cervical pathologists examined the slides. The agreement in the diagnosis between pairs or groups of observers was calculated by kappa statistics. Significant discrepancies were observed in the diagnostic interpretation of hematoxylin and eosin-stained slides, particularly for low-grade lesions (kappa value 0.60 [95% confidence interval 0.58-0.63]). There was significantly better agreement in the interpretation of p16INK4a expression (kappa value 0.91 [95% confidence interval 0.84-0.99]). Expression of p16INK4a was restricted to CIN 2/CIN 3, CIN 1 associated with high-risk human papillomavirus, or cervical cancer. p16INK4a immunostaining allowed precise identification of even small CIN or cervical cancer lesions in biopsy sections and helped to reduce interobserver variation in the histopathologic interpretation of cervical biopsy specimens. Thus, p16INK4a immunohistochemistry can reduce false-negative and false-positive biopsy interpretation and thereby significantly improve cervical (pre)-cancer diagnosis.

KW - Biomarker

KW - Cervical intraepithelial neoplasia

KW - CIN

KW - Histologic diagnosis

KW - Immunohistochemistry

KW - Interobserver variability

KW - p16

KW - Tumor marker

UR - http://www.scopus.com/inward/record.url?scp=0036826860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036826860&partnerID=8YFLogxK

U2 - 10.1097/00000478-200211000-00001

DO - 10.1097/00000478-200211000-00001

M3 - Article

VL - 26

SP - 1389

EP - 1399

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

SN - 0147-5185

IS - 11

ER -